Physician profile
Daniel J Arthur
NPI 1649783010
$454.57
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.90 · 2022: $43.30 · 2023: $249 · 2024: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $132.49 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $104.74 | 2023-2024 | |
| Lilly USA, LLC | $68.92 | 2022-2023 | Mounjaro |
| Idorsia Pharmaceuticals US INC | $31.97 | 2022-2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $30.96 | 2023-2024 | Breztri |
| Sanofi Pasteur INC. | $19.87 | 2023 | |
| Abbvie INC. | $17.59 | 2023 | |
| Glaxosmithkline, LLC. | $17.33 | 2024 | Shingrix, Arexvy |
| Dynavax Technologies Corporation | $16.80 | 2024 | Heplisav-B |
| Amgen INC. | $13.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Arthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.